89bio Revenue

Biotechnology Research • San Francisco, California, United States • 101-200 Employees

89bio revenue & valuation

Annual revenue	$12,200,000
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$38,900,000
Total funding	$562,500,000

Key Contacts at 89bio

Ryan Mccormick

Director Clinical Development

Lisa Ricci

Marketing Associate Director

Laura E Contreras

Director Clinical Operations

Kingsley Macmadu

Associate Director, Quality Systems

Steven Altschuler

Chair Of The Board Of Directors

Scott Cameron

Director Of Engineering Devices And Combination Products

Caroline Padre

Executive Director And Senior Corporate Counsel

Meghann Morris

Sr. Director, Supply Chain

Millie Gottwald Pharmd

Executive Director

Todd Reul

Director, Clinical Business Operations

Company overview

Headquarters	San Francisco, California, United States
Phone number	+14154329270
Website	89bio.com
NAICS	541714
Keywords	Biopharmaceutical
Founded	2018
Employees	101-200
Socials

89bio Email Formats

89bio uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@89bio.com), used 70.5% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@89bio.com	70.5%
{first name}.{last name}	john.doe@89bio.com	29.5%

About 89bio

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company’s lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). Recent Phase 1b/2a data show BIO89-100 demonstrated a favorable safety and tolerability profile and robust reductions in liver fat and key lipid markers when dosed weekly or once every two weeks in patients with NASH. BIO89-100 is currently in a Phase 2 trial for the treatment of SHTG. 89bio is headquartered in San Francisco with operations in Herzliya, Israel. Our culture is best described by our values: • Always putting the patient first • Operating with the highest integrity and ethical standards at all times • Being authentic in all our transactions • Acting as a team – collaborating, respecting and caring for one another • Being entrepreneurial and passionate in our tasks • Being scientific and rational in our thought process and decision-making

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Director

Entry

Senior

Employees by Department

89bio has 58 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore 89bio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2024-01-06	14	$150,000,000
2024-12-12	14	$125,000,000
2025-02-28	14	$287,500,000

Funding Insights

$562,500,000

Total funding amount

$287,500,000

Most recent funding amount

Number of funding rounds

89bio Tech Stack

Discover the technologies and tools that power 89bio's digital infrastructure, from frameworks to analytics platforms.

PWA

Miscellaneous

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Frequently asked questions

89bio is located in San Francisco, California, US.

You can reach 89bio at +14154329270.

89bio generates an estimated annual revenue of $12,148,810. This revenue figure reflects the company's market position and business performance in its industry.

89bio has an estimated valuation of $38,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

89bio was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

89bio has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

89bio has raised a total of $562,500,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at 89bio

Ryan Mccormick

Director Clinical Development

Lisa Ricci

Marketing Associate Director

Laura E Contreras

Director Clinical Operations

Kingsley Macmadu

Associate Director, Quality Systems